Skip to main content

Table 2 HIV integration sites in latently infected cell lines

From: HIV integration sites in latently infected cell lines: evidence of ongoing replication

Cell line

Replication competent virus

Chromosomea

Positionb

Genec

Gene orientationd

HIV orientatione

Percentage of eventsf

U1

Yes

2

48,177,527

AC079807.4

−

+

≈38%

  

X

38,811,467

  

−

≈55%

  

19

34,452,847

UBA2

+

+

≈3%

ACH-2

Yes

7

33,019,791

NT5C3A

−

−

≈37%

  

9

128,111,651

SLC25A25-AS

−

−

≈13%

  

2

26,386,668

EPT1

+

+

≈2%

  

17

81,558,479

NPLOC4

+

−

≈1%

J1.1

Yes

11

685,243

DEAF1

−

−

≈41%

  

12

54,257,973

CBX5

−

−

≈38%

J-Lat 8.4

No

1

7,946,384

FUBP1

−

−

100%

J-Lat 9.2

No

19

4,381,104

PPP5C

+

+

100%

J-Lat 10.6

No

9

136,468,579

SEC16A

−

+

100%

J-Lat 15.4

No

19

34,441,293

UBA2

+

+

100%

J-Lat tat-GFP 8.2

No

10

39,936,068

  

+

100%

J-Lat tat-GFP A1

No

X

34,073,326

  

−

100%

J-Lat tat-GFP H2

No

2

171,821,429

SLC25A12

−

+

100%

J-Lat tat-GFP A72

No

X

45,038,538

KDM6A

+

−

100%

  1. aThe particular chromosome where the HIV integration site is located
  2. bThe first human genome nucleotide following 3′-end LTR
  3. cThe gene where HIV is integrated
  4. dTranscription direction of the gene
  5. eTranscription direction of HIV
  6. fPercentage of events where the particular HIV integration site was detected in all passages